ATLANTA — Jan. 24, 2019 — Bako Diagnostics continues its strong in-network laboratory status with all five national health plans into 2019.
Members covered will continue to have access to Bako Diagnostics’ routine and patented testing, including anatomic pathology, clinical pathology, proprietary DNA testing, microbiology and neuropathy-related test offerings.
“While national payors continuously monitor their laboratory network needs, Bako Diagnostics is proud of our continued contractual relationships with all five national health plans,” said Diana Brandon, Vice President, Strategic Development and Payor Relations at Bako Diagnostics.
Bako Diagnostics’ in-network services are available to more than 250 million covered lives, including all five national health plans and fully compliant patient-friendly billing policies.
For a list of all insurances accepted by Bako Diagnostics, please visit http://bit.ly/2ChO6Mh
DISCLAIMER: Bako Diagnostics is not part of certain capitated networks.